No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: 3-Year Structured Exercise after Adjuvant Chemotherapy Improved Survival for Colon Cancer

byJinny TsangandAlisha Yi

August 7, 2025

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc.Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

An intradialytic exercise intervention did not improve dialysis adequacy

2 Minute Medicine Rewind April 27, 2026

Atezolizumab may improve disease-free survival in mismatch repair deficiency locally advanced colon cancer

Fetal cerebrovascular response to maternal hyperoxia testing may help predict neurodevelopmental outcomes

RelatedReports

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail

Chronic Disease

An intradialytic exercise intervention did not improve dialysis adequacy

May 18, 2026

Development of a risk index for colorectal cancer screening

Weekly Rewinds

2 Minute Medicine Rewind April 27, 2026

April 27, 2026

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening

Oncology

Atezolizumab may improve disease-free survival in mismatch repair deficiency locally advanced colon cancer

April 8, 2026

Chronic Disease

Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer

March 25, 2026

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Bedtime dosing of antihypertensive medications may provide improved outcomes over morning dosing

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

Increased rates of unmet social needs observed shortly following a diagnosis of dementia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result